China Resources Double-Crane Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - China Resources Double-Crane Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 16.16 CNY -0.49%

Market Cap: ¥16.8B

C	China Resources Double-Crane Pharmaceutical Co Ltd SSE:600062	CN
E	Empire Metals Ltd F:NOGN	UK
	News Corp F:NC0E	US
C	Christian Dior SE SWB:DIO	FR
	Mitsui & Co Ltd OTC:MITSF	JP
H	Hf Foods Group Inc NASDAQ:HFFG	US
	Woolworths Holdings Ltd F:WN3	ZA
W	WatosCorea Co Ltd KOSDAQ:079000	KR
	Indofood Agri Resources Ltd SGX:5JS	SG
	Fugro NV OTC:FUGRF	NL

Profitability Summary

China Resources Double-Crane Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

56%

Strong 3Y Average Gross Margin

56%

Gross Margin is Increasing

54% > 56%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

14% > 15%

Healthy Net Margin

15%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

13% > 15%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

10%

Declining Free Cash Flow Margin

10% > 8%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

Declining ROIC

13% > 10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.